A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

NCT00367952 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Avexa